[xoo_el_inline_form active="login"]
BsAb Armed-T™ Therapy Platform
賽昂生醫開創T細胞癌症治療突破性發展
CytoArm’s innovative BsAb Armed-T™ therapy platform utilizes non-viral bi-functional antibodies (BsAb) to empower T cells in targeting tumor cells effectively. This pioneering approach enables adaptable cancer treatments across various oncological conditions, potentially addressing limitless diseases
CytoArm’s Non-Viral BsAb Armed-T™ therapy is a platform that Adaptable and Targeted Cancer Treatments covering over 50 diseases

雙功能抗體 (BsAb) 透過與 T 細胞受體結合,活化免疫系統對腫瘤專一性攻擊

BsAb Armed-T™ cells provide promising adaptable cancer treatments

CytoArm can create BsAb Armed-T™ products to cover more than
50 diseases
50 diseases
賽昂最新動態

了解更多賽昂
